Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Share · CNE100001237 (XSHE)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Staidson (Beijing) BioPharmaceuticals Co., Ltd.

No Price

Closing Price XSHE 29.04.2026: 27,85 CNY

29.04.2026 07:04

Current Prices from Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	300204.SZ	CNY	29.04.2026 07:04	27,85 CNY	0,24 CNY +0,87 %

Share Float & Liquidity

Free Float 91,15 %

Shares Float 435,51 M

Shares Outstanding 477,77 M

Company Profile for Staidson (Beijing) BioPharmaceuticals Co., Ltd. Share

Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.